INAB
IN8bio Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.89
-0.02 ▼ -1.05%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$1.87
-0.02 ▼ -1.06%
| Index | - | P/E | - | EPS (ttm) | -4.59 | Insider Own | 13.12% | Shs Outstand | 0.01B | Perf Week | 9.88% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | 27.87% | Insider Trans | - | Shs Float | 0.01B | Perf Month | -5.03% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -0.54 | Inst Own | 31.56% | Short Float | 1.63% | Perf Quarter | 6.78% |
| Income | -0.02B | P/S | - | EPS this Y | 52.93% | Inst Trans | 30.89% | Short Ratio | 0.49 | Perf Half Y | -9.57% |
| Sales | 0.00B | P/B | 0.67 | EPS next 5Y | 39.02% | ROA | -71.64% | Short Interest | 0.14M | Perf YTD | -19.23% |
| Book/sh | 2.82 | P/C | 0.68 | EPS past 3/5Y | 52.25% 22.63% | ROE | -92.49% | 52W High | -75.05% ($7.57) | Perf Year | -72.16% |
| Cash/sh | 2.77 | P/FCF | - | Sales past 3/5Y | - | ROIC | -66.76% | 52W Low | 61.54% ($1.17) | Perf 3Y | -94.88% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 70.57% | Gross Margin | - | Volatility(W/M) | 11.25% 9.16% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.17 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.82 | EPS Q/Q | 80.15% | Profit Margin | - | RSI (14) | 54.23 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.82 | Sales Q/Q | - | SMA20 | 9.76% ($1.72) | Beta | -0.06 | Target Price | $6.25 |
| Payout | - | Debt/Eq | 0.1 | Earnings | 3000000 | SMA50 | -5.71% ($2) | Rel Volume | 0.22 | Prev Close | $1.91 |
| Employees | 17 | LT Debt/Eq | 0.06 | EPS/Sales Surpr. | 29.74% - | SMA200 | -11.62% ($2.14) | Avg Volume(3M) | 0.28M | Price | $1.89 |
| IPO | 2021/7/30 | Option/Short | No/Yes | Trades | 412 | Volume | 61,134 | Change | -1.05% |
뉴스 로딩 중...